

The Hidden Danger Behind Bone Meds and Steroids -AI Podcast
Jul 5, 2025
Delve into the alarming risks of medication-related osteonecrosis of the jaw linked to popular bone drugs like denosumab. Discover a Finnish study revealing heightened MRONJ risk, especially in long-term users and cancer patients. The discussion stresses the importance of preventive dental care and a nutrient-rich diet to support bone health. It also highlights collagen's role in bone strength and suggests safer exercise alternatives. Tune in for valuable health tips and insights to protect your bones!
AI Snips
Chapters
Transcript
Episode notes
Bone Drugs Cause Jaw Bone Death
- Medication-related osteonecrosis of the jaw (MRONJ) occurs when jawbone dies and won't heal.
- Denosumab users are five times likelier to develop MRONJ than bisphosphonate users, with higher risks for cancer patients and long-term users.
Jawbone's Unique Vulnerability
- The jawbone sustains constant microinjuries but has limited blood supply.
- Bone drugs block normal turnover, preventing repair and causing lesions or necrosis.
Drug Delivery and Switching Risks
- Intravenous or subcutaneous delivery of bone drugs causes more damage than pills.
- Switching from bisphosphonates to denosumab doubles MRONJ risk among low-dose users.